ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2650

The Meteor Trial: Preliminary Results of an RCT of Arthroscopic Partial Meniscectomy Vs. Physical Therapy in Patients greater Than 45

Jeffrey N. Katz1, Christine E. Chaisson2, Brian Cole3, Laurel Donnell-Fink1, Morgan Jones4, Bruce Levy5, Lisa A. Mandl6, Scott Martin1, Robert Marx7, Anthony Miniaci8, Joseph Palmisano9, Emily Reinke10, Clare Safran-Norton1, Debra J. Skoniecki11, Daniel Solomon12, Kurt P. Spindler10, John Wright13, Rick Wright14 and Elena Losina15, 1Brigham and Women's Hospital, Boston, MA, 2Boston University School of Public Health, Boston, MA, 3Rush University, Chicago, IL, 4Orthopedic Surgery, Cleveland Clinic, Cleveland, OH, 5Orthopedics, Mayo Clinic, Rochester, MN, 6Rheumatology, Hospital for Special Surgery, New York, NY, 7Orthopedic Surgery, Hospital for Special Surgery, New York, NY, 8Orthopedics, Cleveland Clinic, Cleveland, OH, 9Boston University School of Public Health, 10Vanderbilt University, Nashville, TN, 11Brigham & Womens Hospital, Boston, MA, 12Division of Rheumatology, Brigham & Womens Hospital, Boston, MA, 13Orthopedic Surgery, Brigham and Women's Hospital, Boston, MA, 14Orthopedics, Washington University, Saint Louis, MO, 15Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Arthroscopy, meniscectomy, osteoarthritis and physical therapy

  • Tweet
  • Email
  • Print
Session Information

Title: Orthopedics, Low Back Pain, and Rehabilitation

Session Type: Abstract Submissions (ACR)

Background/Purpose: Patients who present with a symptomatic knee that has both osteoarthritis and a meniscal tear present a difficult treatment challenge. They may be treated nonoperatively or with arthroscopic partial meniscectomy (APM); there is limited data on the comparative outcomes of these treatments.

Methods: We conducted a randomized controlled trial in 7 US centers involving 351 subjects > 45 years old with symptomatic meniscal tear and osteoarthritic cartilage change, documented by magnetic resonance imaging (MRI). To be eligible, subjects must have exhibited meniscus related symptoms for at least 4 weeks. Enrolled subjects were randomized to APM with postoperative physical therapy (APM arm) or to nonoperative care including a standardized PT regimen focused on strengthening (non-operative arm).  The primary analysis compared change in functional status (WOMAC) over 6 months across the 2 arms, using an intention to treat (ITT) approach.  A secondary outcome was a binary variable defined as lack of improvement in WOMAC function of at least 8 points over 6 months (a clinically relevant change) OR unplanned cross-over (from nonoperative therapy to APM or from APM to nonoperative therapy). We carried 3 month observations forward to address missing 6 month outcome data.

Results: 174 subjects were randomized to APM and 177 to the nonoperative arm. The arms were balanced with respect to baseline function, radiographic severity, age and sex. The response rate at 6 months was 84% across both arms. In the ITT analysis, mean improvement in WOMAC function after 6 months was 19.4 points (sd 18.4) in subjects randomized to APM and 16.8 (sd 18.1) in those randomized to the nonoperative arm (p=0.19). Of the 174 randomized to APM, 9 (5%) did not receive surgery by 6 months. Of the 177 subjects randomized to the non-operative arm, 53 (30%) crossed over and had APM by 6 months (Table). In the analysis of the secondary outcome, 26% of subjects randomized to APM vs. 51% of subjects in the nonoperative arm either did not improve by at least 8 points on WOMAC function or crossed over (p<0.0001; Table).

Conclusion: These preliminary trial findings suggest that in both the APM and the nonoperative arms, subjects experienced substantial improvement in functional status over six months, with no significant differences between the two arms in the ITT analysis.   30% of subjects randomized to nonoperative therapy underwent APM within the first six months. As with all RCT’s the results should be generalized cautiously to clinical populations. These findings will aid physicians and their patients over 45 who present with knee symptoms in association with meniscal tears and osteoarthritis as they decide whether to elect APM or nonoperative therapy. 

Table: Crossovers and functional outcomes at six months in the randomized arms

Randomized arm

No crossover

Crossover

WOMAC improvement ≥ 8

WOMAC improvement < 8

APM

129 (74%)

36 (21%)

9 (5%)

Nonoperative

86 (49%)

38 (22%)

53 (30%)


Disclosure:

J. N. Katz,
None;

C. E. Chaisson,
None;

B. Cole,
None;

L. Donnell-Fink,
None;

M. Jones,
None;

B. Levy,
None;

L. A. Mandl,
None;

S. Martin,
None;

R. Marx,
None;

A. Miniaci,

Zimmer, Arthrosurface, Medtronic, Smith and Nephew, Johnson and Johnson,

1,

Zimmer, Arthrosurface,

7;

J. Palmisano,
None;

E. Reinke,
None;

C. Safran-Norton,
None;

D. J. Skoniecki,
None;

D. Solomon,
None;

K. P. Spindler,
None;

J. Wright,
None;

R. Wright,
None;

E. Losina,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-meteor-trial-preliminary-results-of-an-rct-of-arthroscopic-partial-meniscectomy-vs-physical-therapy-in-patients-greater-than-45/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology